Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under PALISADE BIO, INC. in our court records and SEC 8-K records (as of 2026-10-18).
- Leadership changes: the latest reported is Jordan Zwick, Director (Form 8-K filed 2026-06-11). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Soleus Capital Master Fund, L.P. (filed 2026-08-13).
Who is behind it
PALISADE BIO, INC.: incorporated in Delaware; business address in Carlsbad, California; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-08-14).
Officers and directors, each with the role and the filing that names them:
- J.D. Finley: Executive Officer, Director (Form D, 2024-05-10)
- Mitchell Jones: Executive Officer (Form D, 2024-05-10)
- Donald Williams: Director (Form D, 2024-05-10)
- Margery Fischbein: Director (Form D, 2024-05-10)
- Binxian Wei: Director (Form D, 2024-05-10)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Commodore Capital LP | 0% |
| Schedule 13G/A, 2026-08-13 | Soleus Capital Master Fund, L.P. | 7.5% |
| Schedule 13G, 2026-07-29 | Blackrock, Inc. | 6% |
| Schedule 13G, 2026-05-27 | Soleus Capital Master Fund, L.P. | 5.4% |
| Schedule 13G/A, 2026-05-15 | Commodore Capital LP | 7.2% |
| Schedule 13G/A, 2026-05-15 | Ra Capital Management, L.P. | 9.9% |
| Schedule 13G/A, 2026-05-15 | Perceptive Advisors LLC | 7.9% |
| Schedule 13G, 2026-05-15 | Ameriprise Financial, Inc. | 5.3% |
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-06-11 | Jordan Zwick | Director | appointed | |
| Form 8-K, 2026-06-11 | Jordan Zwick | appointed |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2024-05-10 | $4M | $4M |
| Form D, 2024-02-13 | $2.50M | $2.50M |
| Form D, 2023-04-10 | $4M | $4M |
| Form D, 2023-01-19 | $2.50M | $2.50M |
Latest IPO step: PALISADE BIO, INC. filed its final IPO prospectus, ticker PALI (424B4, 2025-10-02).
IPO filings: 424B4, 2025-10-02, S-1, 2025-09-29, RW, 2025-06-12, S-1, 2025-05-27, S-1/A, 2024-12-09; ticker PALI on Nasdaq Capital Market.
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/palisade-bio